What is NexGenAbler Technology?
RhoDx’s Proprietary NexGenAbler™ technology is a novel NGS workflow enabling specific, ultrasensitive detection of circulating tumor DNA (ctDNA). NexGenAbler™ supports early cancer detection and serial measurement of key oncogenic drivers to improve cancer research and drive mechanistic cancer management.
We’re developing standard protocols and reagents sets for measuring most important biomarkers. What better place to start than targets critical to your research. Work with us today to ensure we’re developing the assays you need in your lab!